TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
about
Mouse models of liver cancer: Progress and recommendationsControl of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 GenesA novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targetsCUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transitionBTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.Oxidative stress and pulmonary changes in experimental liver cirrhosis.Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells.Experimental mouse models for hepatocellular carcinoma research.A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress β-catenin nuclear translocationThe Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration.Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.MicroRNAs control hepatocyte proliferation during liver regeneration.B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.Knockdown of MALAT1 expression inhibits HUVEC proliferation by upregulation of miR-320a and downregulation of FOXM1 expression.BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.PPARα-Target Gene Expression Requires TIS21/BTG2 Gene in Liver of the C57BL/6 Mice under Fasting Condition.PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet.Oncogenic Actions of SKP2 Involves Deregulation of CDK1 Turnover Mediated by FOXM1.Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression.Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.Regulation of the master regulator FOXM1 in cancer
P2860
Q26799788-42F487C8-FFE0-40DC-B84C-35FAF83AB14DQ28261895-8C390A62-E84B-44C2-AE32-DCF3AA0A9BA5Q28508329-691F4F5A-4C75-40DB-AE9B-31C45164E3C7Q36305413-BC18112F-0678-4EF5-B2FF-4117A0D74DEFQ36375110-4A5BB047-D2A1-4A23-8013-143A2991EBF0Q36497856-DD8BF7DD-1B44-40D9-B763-C257CFEA0B81Q37028411-D2A9EB81-8C0B-46FB-961A-B169C2B50251Q37365789-8E32D093-C390-4BE2-B00B-DD3EB88553B6Q37574072-451DF046-BE24-4727-B7F0-75566B4DD65AQ37737865-CA26847D-D045-4AA0-BBC3-C40F998A124EQ38178032-96707671-4109-4F7B-8284-3F082BDE10BBQ38327797-C948CF97-0CB7-4626-9A1A-C64F6BD0CCA3Q38896410-C2C5F63A-2C4E-43F7-A5B9-6DF9C6E7A244Q39116768-2F84ECEA-6076-487A-8B71-DDBDAE0BF8F3Q39352908-517D14DD-10EF-4359-8AAA-9423FBB4CF2BQ39590768-C1FBB6FC-780F-4833-9A0F-C7173DF7CB2DQ42119736-5DA92FE4-EE42-429F-AA7B-037D2BFF8C79Q42184828-10EEA0B0-DF14-4AF6-84D4-04246D5A783CQ42365277-A15E2747-B38A-4407-AEAC-60075BA9189AQ47446427-BEDF9068-0723-409A-8FB2-D5B4F401624EQ49550796-9F51CA9F-81EA-45D0-8F73-237BD47B1604Q50019708-7B5CB0EE-7C05-4065-8019-0AB43F66F64CQ50534138-FA00211A-35C1-40FA-9891-69307A3CF991Q51449926-A2983E4D-69BD-4C81-92B5-3B425D8ED37EQ52689090-3A2ABC5A-9169-4411-A15D-96D1794D5C21Q55255442-9A738937-A2A2-465B-A75C-AF676753044FQ58748301-8AA13F55-296E-4DDA-9738-C90F7D59FCDC
P2860
TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@en
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@nl
type
label
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@en
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@nl
prefLabel
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@en
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@nl
P2093
P2860
P356
P1433
P1476
TIS21 negatively regulates hep ...... rkhead box M1 regulation loop.
@en
P2093
Bong Wan Kim
Hee Jung Wang
Hyoung Chin Kim
In Kyoung Lim
Ji Yeon Kim
Kye Yong Song
So Young Kang
Tae Jun Park
P2860
P304
P356
10.1002/HEP.22212
P407
P577
2008-05-01T00:00:00Z